<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Therap Adv Gastroenterol</journal-id>
<journal-id journal-id-type="iso-abbrev">Therap Adv Gastroenterol</journal-id>
<journal-id journal-id-type="publisher-id">TAG</journal-id>
<journal-id journal-id-type="hwp">sptag</journal-id>
<journal-title-group>
<journal-title>Therapeutic Advances in Gastroenterology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1756-283X</issn>
<issn pub-type="epub">1756-2848</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26929784</article-id>
<article-id pub-id-type="pmc">4749851</article-id>
<article-id pub-id-type="doi">10.1177/1756283X15607414</article-id>
<article-id pub-id-type="publisher-id">10.1177_1756283X15607414</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Fecal microbiota transplantation: in perspective</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gupta</surname>
<given-names>Shaan</given-names>
</name>
<aff id="aff1-1756283X15607414">Department of Medicine, Gastrointestinal Diseases Research Unit, Queen’s University, Kingston, ON, Canada</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Allen-Vercoe</surname>
<given-names>Emma</given-names>
</name>
<aff id="aff2-1756283X15607414">Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petrof</surname>
<given-names>Elaine O.</given-names>
</name>
<xref ref-type="corresp" rid="corresp1-1756283X15607414"></xref>
<aff id="aff3-1756283X15607414">Department of Medicine, Queen’s University, Gastrointestinal Diseases Research Unit Wing, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2V7, Canada</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-1756283X15607414">
<email>eop@queensu.ca</email>
</corresp>
<fn fn-type="conflict">
<p><bold>Conflict of interest statement:</bold> The authors declare that there is no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<volume>9</volume>
<issue>2</issue>
<fpage>229</fpage>
<lpage>239</lpage>
<permissions>
<copyright-statement>© The Author(s), 2015</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>There has been increasing interest in understanding the role of the human gut microbiome to elucidate the therapeutic potential of its manipulation. Fecal microbiota transplantation (FMT) is the administration of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient’s gut microbial composition and confer a health benefit. FMT has been used to successfully treat recurrent <italic>Clostridium difficile</italic> infection. There are preliminary indications to suggest that it may also carry therapeutic potential for other conditions such as inflammatory bowel disease, obesity, metabolic syndrome, and functional gastrointestinal disorders.</p>
</abstract>
<kwd-group>
<kwd>bacteriotherapy</kwd>
<kwd><italic>Clostridium difficile</italic> infection</kwd>
<kwd>fecal microbiota transplantation</kwd>
<kwd>gut microbiome</kwd>
<kwd>inflammatory bowel disease</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>